“IL was very helpful in optimizing our hospital system’s COVID-19 response.  Early in the pandemic, we were concerned about our ability to meet the 30% increase in blood-gas testing demand. We considered ordering a surplus of GEM PAK cartridges for the GEM Premier systems throughout our system. Instead, IL proposed an alternative option to increase the test size of our GEM PAKs. This flexibility allowed us to increase our testing capacity without increasing our reagent-storage capacity, and ultimately saved our system thousands of dollars.”


—Lois Schultz, POCT Technical Coordinator at University Hospitals Cleveland Medical Center


The U.S. Food and Drug Administration released new guidance related to the use of viscoelastic testing for hospitalized patients suspected of a COVID-19 associated coagulopathy.


A Clinical Perspective on Hemostasis and Viscoelastic Testing During COVID-19






"As many of us in healthcare have seen lately, patient care doesn’t stop for pandemics, nor do our everyday responsibilities. In addition to all that was new to address COVID-19, it was imperative that our ongoing project to replace our coagulation platform stay on-track, as our current platform was at the end of life and failing. We had selected IL and their ACL TOP Family 50 Series Hemostasis Testing Systems as our new platform for 14 locations across our healthcare system, in addition to HemoCell Automation. Just as we were scheduled to begin the install and training, COVID-19 hit, and with that came new challenges and restrictions, drastically affecting “business as usual.”

While moving forward was essential, safety restrictions prevented our staff from travelling to IL headquarters for in-person training on the new systems. So instead of the typical training model, IL brought the training to us—a first outside of their facility. The two-week training program could not have been better. The trainers set up the many analyzer models they’d shipped, allowing our teams to work in small groups at a safe distance, in full PPE. They were knowledgeable, flexible, personable and committed. As a result of their extraordinary efforts and those of our staff, we are on track for our go-live date and our team is prepared. Thanks to IL and their adaptability, I have no doubt this conversion will be very successful."


Frank A. Beylo, BS, MT (ASCP), Director of Operations
and Technology, Laboratory Services, Inova Health System






Managing POCT During COVID-19: Insights from a Large Reference Laboratory

Featuring webinars on Hemostasis and COVID-19

Werfen Academy features webinars related to COVID-19, including:

  • Thrombosis, Thromboprophylaxis and Coagulopathy in COVID-19 Infections
  • Thrombotic and Hemostatic Issues in Critical Care Units Managing COVID-19
  • Thrombosis in the Hospitalized COVID Positive Patient
  • COVID-19 Hypercoagulability
  • Coagulopathy and Thromboembolism in COVID-19 Patients in Special Populations
  • SARS CoV2 Vaccine-Related Thromboembolic Complications


IL Employees Dedicated to Uninterrupted Product Supply and Customer Support



Thank you, Operations and Field Support teams for your dedication during COVID-19!